Humacyte Stock Forecast

Sell candidate since May 29, 2026 Loss -80.12%

The Humacyte, Inc. stock price gained 11.11% on the last trading day (Friday, 31st Jul 2026), rising from $0.0090 to $0.0100. During the last trading day the stock fluctuated 2,775.00% from a day low at $0.0080 to a day high of $0.230. The price has risen in 5 of the last 10 days and is up by 8.7% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 490 thousand more shares were traded than the day before. In total, 514 thousand shares were bought and sold for approximately $5.14 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.0050, a level that may pose a second chance to hit a runner. According to fan-theory $0.0449 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

HUMAW Signals & Forecast

There are mixed signals in the stock today. The Humacyte, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0109. On a fall, the stock will find some support from the short-term average at $0.0096. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -5.66%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Humacyte, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Humacyte, Inc. stock

Humacyte, Inc. finds support from accumulated volume at $0.0098 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.222 between high and low, or 2,775.00%. For the last week, the stock has had daily average volatility of 2,607.78%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HUMAW) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Humacyte, Inc. to open at $0.0827, and during the day (based on 14 day Average True Range), to move between $0 and $0.0940, which gives a possible trading interval of +/-$0.168 (+/-93 979.78%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 93 979.78% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

Since the stock is closer to the support from accumulated volume at $0.0098 (2.00%) than the resistance at $0.0106 (6.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Humacyte, Inc. stock A Buy?

Humacyte, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.144 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.0827 ( 726.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk